Triulzi, Tiziana <br/><br/>
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit.  [electronic resource] 

 -  British journal of cancer  12 2018 
 - 1487-1494 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/s41416-018-0318-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Genes, MHC Class II<br/>Humans<br/>Immunologic Factors--pharmacology<br/>Ki-67 Antigen--analysis<br/>Mice<br/>Receptor, ErbB-2--analysis<br/>Transcriptome<br/>Trastuzumab--pharmacology<br/>Tumor Microenvironment